| For: | Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron. World J Diabetes 2019; 10(3): 169-180 [PMID: 30891152 DOI: 10.4239/wjd.v10.i3.169] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v10/i3/169.htm |
| Number | Citing Articles |
| 1 |
Lumei Liu, Neng Wang, Bill Kalionis, Shijin Xia, Qinghu He. HMGB1 plays an important role in pyroptosis induced blood brain barrier breakdown in diabetes-associated cognitive decline. Journal of Neuroimmunology 2022; 362 doi: 10.1016/j.jneuroim.2021.577763
|
| 2 |
Chhatrapal Patel, Richa Patel, Vaibhav Maturkar, Venu Anand Das Vaishnav, Nishant Sudhir Jain. Enhanced central histaminergic transmission via H1 and H2 receptor alleviates the behavioral despair, reduction in BDNF and pCREB levels in streptozotocin-induced diabetic mice. Behavioural Brain Research 2026; 504 doi: 10.1016/j.bbr.2026.116102
|
| 3 |
Jae-ho Jeong, Dong Hoon Lee, Juhyun Song. HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation. Biomedicine & Pharmacotherapy 2022; 150 doi: 10.1016/j.biopha.2022.112933
|
| 4 |
Analía Foncea-Bitrán, Cristián Barros-Osorio, Francisca Arriaza, Catalina Ramírez-López, Lina M. Ruiz, Marlen Barreto, Fernando C. Ortiz, Francisca Cornejo, Gonzalo I. Gómez. Connecting the Dots: Neurobiological Interplay Between Type 2 Diabetes and Alzheimer’s Disease. International Journal of Molecular Sciences 2026; 27(7) doi: 10.3390/ijms27073225
|
| 5 |
Isaac Oluwatobi Akefe, Victoria Aderonke Adegoke, Ibrahim Yusuf Lamidi, Matthew Phillip Ameh, Enokela Shaibu Idoga, Simon Azubuike Ubah, Itopa Etudaye Ajayi. Myrtenal mitigates streptozotocin-induced spatial memory deficit via improving oxido inflammatory, cholinergic and neurotransmitter functions in mice. Current Research in Pharmacology and Drug Discovery 2022; 3 doi: 10.1016/j.crphar.2022.100106
|
| 6 |
Isaac Oluwatobi Akefe, Ezekiel Stephen Nyan, Victoria Aderonke Adegoke, Ibrahim Yusuf Lamidi, Matthew Phillip Ameh, Uchendu Chidiebere, Simon Azubuike Ubah, Itopa Etudaye Ajayi. Myrtenal improves memory deficits in mice exposed to radiofrequency-electromagnetic radiation during gestational and neonatal development via enhancing oxido-inflammatory, and neurotransmitter functions. Heliyon 2023; 9(4) doi: 10.1016/j.heliyon.2023.e15321
|
| 7 |
Francisco Mercado, Michaela Kop, Michelle Trinh. GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review. Discover Medicine 2025; 2(1) doi: 10.1007/s44337-025-00428-0
|
| 8 |
Habib Yaribeygi, Milad Ashrafizadeh, Neil C. Henney, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Neuromodulatory effects of anti-diabetes medications: A mechanistic review. Pharmacological Research 2020; 152 doi: 10.1016/j.phrs.2019.104611
|
| 9 |
Noriko Shinjyo, James Parkinson, Jimmy Bell, Tatsuro Katsuno, Annie Bligh. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Journal of Integrative Medicine 2020; 18(2) doi: 10.1016/j.joim.2020.01.004
|
| 10 |
Ravi Kiran Morampudi, Vishali Neelakandan, Bandarupalli Naveen Kumar, Edward Indla. Evaluation of Cognitive and Synaptic Restoration in Diabetic Rats Treated With Emblica officinalis, Clitoria ternatea, Vitamin C, and Metformin. Cureus 2024; doi: 10.7759/cureus.75866
|
| 11 |
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel del Marco, Marta Herrera, Maria Jose Carranza-Naval, Javier Suarez, Pilar Alves-Martinez, Simon Lubian-Lopez, Monica Garcia-Alloza. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes. Alzheimer's Research & Therapy 2020; 12(1) doi: 10.1186/s13195-020-00607-4
|
| 12 |
Yane Costa Chaves, Karina Genaro, José Alexandre Crippa, Joice Maria da Cunha, Janaína Menezes Zanoveli. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease 2021; 36(4) doi: 10.1007/s11011-020-00667-3
|
| 13 |
Nabeel Kinattingal, Venugopal Bovilla, Seema Mehdi, Mahadevaswamy G. Kuruburu, K. Nandakumar, Santhepete N. Manjula. Reversal of diabetes-associated cognitive impairment through modulation of BDNF, insulin, and NF-κB pathways by a marketed herbal formulation. 3 Biotech 2026; 16(6) doi: 10.1007/s13205-026-04827-7
|
| 14 |
Wei Liu, Yi Zhou, Rui Liang, Yue Zhang. Inhibition of cyclin‐dependent kinase 5 activity alleviates diabetes‐related cognitive deficits. The FASEB Journal 2019; 33(12) doi: 10.1096/fj.201901292R
|
| 15 |
K. Sh. Magomedova, Yu. V. Bykov, V. A. Baturin. Diabetic ketoacidosis and cognitive impairment in children and adolescents. Bulletin of Siberian Medicine 2023; 22(3) doi: 10.20538/1682-0363-2023-3-132-140
|
| 16 |
Punita Aggarwal, Faiz Khan, Sugato Banerjee. Metabolic Disorder Therapeutics and their Effects on Memory. CNS & Neurological Disorders - Drug Targets 2024; 23(9) doi: 10.2174/0118715273269329231013074613
|
| 17 |
Wenjie Zhang, Shihong Chen, Xianghua Zhuang. Research Progress on Lipocalin-2 in Diabetic Encephalopathy. Neuroscience 2023; 515 doi: 10.1016/j.neuroscience.2023.02.011
|